Your Web Site
Taro Pharma and NextWave to co-promote head lice drug
pharmaceutical-business-review.com Aug 2, 2008 4 relatedTaro Pharmaceutical Industries and NextWave Pharmaceuticals have announced that Taro's US subsidiary and NextWave have entered into an agreement to co-promote Ovide lotion, 0.5% in the US. Under the agreement Taro will retain...

